Nicholas J. Singer - 02 Dec 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role: Director
Signature: /s/ Nicholas J. Singer
Issuer symbol: ERNA
Transactions as of: 02 Dec 2022
Net transactions value: +$1,000,000
Form type: 4
Filing time: 06 Dec 2022, 17:52:09 UTC
Previous filing: 03 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ERNA	Common Stock	Purchase	$232,296	+70,822	+139%	$3.28	121,822	02 Dec 2022	By Purchase Capital LLC	F1
transaction	ERNA	Common Stock	Purchase	$696,882	+212,464	+395%	$3.28	266,214	02 Dec 2022	By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Warrants (right to buy)	Purchase	$17,706	+141,644		$0.1250^*	141,644	02 Dec 2022	Common Stock, par value $0.005 per share	141,644	$3.28	By Purchase Capital LLC	F1
transaction	ERNA	Warrants (right to buy)	Purchase	$53,116	+424,928		$0.1250^*	424,928	02 Dec 2022	Common Stock, par value $0.005 per share	424,928	$3.28	By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.

Content

The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.